French guidelines on <scp>TIPS</scp>: Indications and modalities-Reference-Cited by-同舟云学术

French guidelines on TIPS: Indications and modalities

Published:2024-05-17 Issue:9 Volume:44 Page:2125-2143
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver International

Author:

Larrue Hélène¹,Allaire Manon²^ORCID,Weil‐Verhoeven Delphine³⁴^ORCID,Barge Sandrine⁵,Thabut Dominique²^ORCID,Payance Audrey⁶,Moga Lucile⁶,Jézéquel Caroline⁷,Artru Florent⁷,Archambeaud Isabelle⁸,Elkrief Laure⁹^ORCID,Oberti Frédéric¹⁰,Roux Charles¹¹,Laleman Wim¹²^ORCID,Rudler Marika²,Dharancy Sébastien¹³,Laborde Nolwenn¹⁴,Minello Anne¹⁵,Mouillot Thomas¹⁵,Desjonquères Elvire¹⁶,Wandji Line Caroll Ntandja¹⁷,Bourlière Marc¹⁸,Ganne‐Carrié Nathalie¹⁹,Bureau Christophe¹^ORCID,

Affiliation:

1. Service d'Hépatologie Hopital Rangueil CHU Toulouse et Université Paul Sabatier Toulouse France

2. Service d'Hépato‐gastroentérologie, Hôpital Universitaire Pitié‐Salpêtrière AP‐HP Sorbonne Université Paris France

3. Service d'Hépatologie et Soins intensifs digestifs, CHU Jean Minjoz Besançon France

4. Université de Franche‐Comté, CHU Besançon, EFS, INSERM, UMR RIGHT Besançon France

5. Service d'Hépato‐gastro‐entérologie, Centre Hospitalier Intercommunal de Créteil Creteil France

6. AP‐HP, Hôpital Beaujon, Service d'Hépatologie, DMU DIGEST, Centre de Référence des Maladies Vasculaires du Foie, FILFOIE, ERN RARE‐LIVER, Centre de recherche sur l'inflammation, Inserm, UMR 1149 Université de Paris Paris France

7. Service des Maladies du Foie, CHU Rennes Rennes France

8. Hépato‐Gastro‐Entérologie et Assistance Nutritionnelle‐Institut des Maladies de l'Appareil Digestif (IMAD), CHU Nantes—Inserm CIC 1413 Nantes France

9. Service d'Hépato‐Gastroentérologie, Hôpital Trousseau CHRU de Tours et Faculté de Médecine de Tours Tours France

10. Service d'Hépato‐Gastroentérologie, CHU Angers Angers France

11. Service de Radiologie Intervent.ionnelle, AP‐HP Sorbonne Université Hôpital Universitaire Pitié‐Salpêtrière Paris France

12. Service de Gastroentérologie et Hépatologie Hôpital Universitaire Gasthuisberg, KU Leuven Louvain Belgium

13. CHU Lille, Hôpital Huriez, Maladies de l'Appareil Digestif, 2 Rue Michel Polonovski Lille France

14. Gastro‐Entérologie, Hépatologie, Nutrition, Maladies Héréditaires du Métabolisme Pédiatriques, Centre de Compétence Maladies Rares du Foie Hôpital des Enfants, CHU Toulouse France

15. Service D'hépato‐Gastroentérologie et Oncologie Médicale, CHU F. Mitterrand Dijon France

16. AP‐HP Sorbonne Paris Nord Hôpitaux Universitaire Paris Seine Saint‐Denis, Service d'Hépatologie Bobigny France

17. Inserm, CHU Lille, U1286—INFINITE—Institute for Translational Research in Inflammation University of Lille Lille France

18. Département d'Hépatologie et Gastroentérologie Hôpital Saint Joseph Marseille France

19. AP‐HP Sorbonne Paris Nord, Hôpitaux Universitaire Paris Seine Saint‐Denis, Service d'Hépatologie, Bobigny, France Centre de Recherche des Cordeliers Sorbonne Université, INSERM, Université de Paris Paris France

Abstract

AbstractTransjugular intrahepatic portosystemic shunt (TIPS) has become essential in the treatment or prevention of portal hypertension‐related complications. In the early 1990s, the primary indication was refractory bleeding. It is now proposed for the treatment of ascites for the prevention of bleeding and in patients with vascular diseases of the liver. Thus, there are a growing number of patients being treated with TIPS all over the world. The broadening of indications, the involvement of multiple stakeholders, the need for an accurate selection, the positioning in relation to transplantation and the lack of standardization in pre‐therapeutic assessment, in the procedure itself and in the follow‐up have led the board of the French Association for the Study of the Liver to establish recommendations.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.15976

Reference134 articles.

1. Serum bilirubin and platelet count: A simple predictive model for survival in patients with refractory ascites treated by TIPS

2. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival

3. Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Indications and posttransjugular intrahepatic portosystemic shunt complications in 2020

4. Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A randomized controlled trial

5. Direct intrahepatic portocaval shunt (DIPS) or transjugular transcaval intrahepatic portosystemic shunt (TTIPS) to treat complications of portal hypertension: Indications, technique, and outcomes beyond Budd-Chiari syndrome